Table 4. Adverse pregnancy outcomes of enrolled pregnant women during follow up.
| Variables | Total | BMI <24 | BMI ≥24 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| H. pylori infection | No H. pylori infection | P value | H. pylori infection | No H. pylori infection | P value | H. pylori infection | No H. pylori infection | P value | |||
| Number | 78 | 242 | 52 | 159 | 26 | 83 | |||||
| GDM | 18 (23.1%) | 26 (10.7%) | 0.006 | 5 (9.6%) | 10 (6.3%) | 0.418 | 13 (50.0%) | 16 (19.3%) | 0.002 | ||
| Preeclampsia | 12 (15.4%) | 15 (6.2%) | 0.011 | 3 (5.8%) | 4 (2.5%) | 0.255 | 9 (34.6%) | 11 (13.3%) | 0.014 | ||
| SPB | 2 (2.7%) | 8 (3.3%) | 0.743 | 1 (1.9%) | 6 (3.8%) | 0.518 | 1 (3.8%) | 2 (2.5%) | 0.696 | ||
| FGR | 8 (10.3%) | 21 (8.7%) | 0.673 | 2 (3.8%) | 8 (5.0%) | 0.727 | 6 (23.1%) | 13 (15.7%) | 0.385 | ||
| Uncomplicated pregnancy | 46 (59.0%) | 172 (71.1%) | 0.046 | 38 (73.1%) | 121 (76.1%) | 0.661 | 8 (30.8%) | 51 (61.4%) | 0.006 | ||
BMI, body mass index; GDM, gestational diabetes mellitus; SPB, spontaneous preterm birth; FGR, fetal growth restriction.